Application of 23-gauge transconjunctival sutureless vitrectomy system for vitreoretinopathy disease
HU Xia-Yun,XING Yi-Qiao,HE Tao,MEI Hai-Feng,WU Li-Na
DOI: https://doi.org/10.13389/j.cnki.rao.2010.07.020
2010-01-01
Abstract:Objective To investigate the application of 23-gauge transconjunctival sutureless vitrectomy system in the treatment of vitreoretinopathy disease and evaluate its efficacy and safety.Methods A retrospective case of 23-gauge vitrectomy performed in 42 cases (43 eyes) in our hospital from August 2008 to September 2009.The diseases included idiopathic macular hole(16 eyes,37.2%),idiopathic macular epiretinal membrane(8 eyes,18.6%),vitreous hemorrhage(19 eyes,44.2%).The main observations were the surgical effects,surgical time,best corrected visual acuity,intraocular pressure,intraoperative and postoperative complications.The follow-up time was from 1 month to 10 months.Results All cases were successfully completed surgery and each surgical indication experienced a significant best corrected visual acuity improvement.The mean best corrected visual acuity was 0.88±0.54 at postoperative 1 week and 0.46±0.24 at the last follow-up;Compared with that before operation,there were all significant statistical differences(all P<0.01).The mean intraocular pressure at postoperative 1 week was (14.0±4.5) mmHg (1 kPa=7.5 mmHg),closed to preoperative level.The intraoperative complications included intubation tube slippage in 2 eyes,little hemorrhage under conjunctiva in 6 eyes,bubble under conjunctiva in 3 eyes;No serious postoperative complication was observed during the follow-up time in all cases.Conclusion 23-gauge transconjunctival sutureless vitrectomy system with faster postoperative recovery,better curative effect and rare complications,is an effective and safe surgical technique in the management of macular diseases and vitreous hemorrhage currently.